Bioinformatics and cell reprogramming to develop an in vitro platform to discover new drugs for progressive multiple sclerosis (BRAVEinMS)

Principal Investigators:

• IVANO EBERINI

Financing institution:

NATIONAL MULTIPLE SCLEROSIS SOCIETY

Type:

INTLI - Finanziamenti internazionali

Project leader:

FONDAZIONE CENTRO SAN RAFFAELE

Year:

2018

Duration:

48

Status:

Closed